HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroki Masuda Selected Research

Hiroki Masuda Research Topics

Disease

9Neuromyelitis Optica (Devic's Disease)
09/2022 - 01/2013
9Multiple Sclerosis
12/2021 - 07/2015
3Nervous System Diseases (Neurological Disorders)
11/2020 - 06/2017
2Seizures (Absence Seizure)
09/2022 - 05/2014
2Neoplasms (Cancer)
08/2020 - 01/2020
2Inflammation (Inflammations)
01/2018 - 01/2017
2Infections
09/2003 - 01/2002
2Human Influenza (Influenza)
09/2003 - 01/2002
2Parkinson Disease (Parkinson's Disease)
09/2003 - 01/2002
1Neuralgia (Stump Neuralgia)
09/2022
1Disease Progression
04/2022
1Optic Neuritis (Retrobulbar Neuritis)
04/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Tissue Adhesions
10/2021
1Cryptococcal Meningitis
08/2021
1Myelitis
11/2020
1Neuroinflammatory Diseases
11/2020
1Atrophy
08/2019
1Progressive Multifocal Leukoencephalopathy
05/2018
1Pain (Aches)
01/2018
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018
1Fatigue
01/2018
1Lymphopenia (Lymphocytopenia)
01/2018
1Relapsing-Remitting Multiple Sclerosis
07/2017
1Pure Autonomic Failure
12/2014
1Epilepsia Partialis Continua
05/2014
1Hashimoto's encephalitis
05/2014
1Myoclonus (Nocturnal Myoclonus)
05/2014
1Brain Diseases (Brain Disorder)
05/2014
1Sclerosis
01/2013

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
11/2020 - 01/2013
4Interleukin-6 (Interleukin 6)IBA
09/2022 - 06/2017
4Fingolimod Hydrochloride (FTY720)FDA Link
08/2021 - 09/2015
4Pharmaceutical PreparationsIBA
08/2019 - 01/2002
3Myelin-Oligodendrocyte GlycoproteinIBA
04/2022 - 01/2020
3Immunoglobulin G (IgG)IBA
04/2022 - 01/2020
2Monoclonal AntibodiesIBA
09/2022 - 01/2020
2Rotaxanes (Rotaxane)IBA
08/2020 - 01/2020
2CyclodextrinsIBA
08/2020 - 01/2020
2CD40 Ligand (CD40L)IBA
01/2018 - 01/2017
2AlbuminsIBA
01/2018 - 07/2017
2Amantadine (Aman)FDA LinkGeneric
09/2003 - 01/2002
1satralizumabIBA
09/2022
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Alemtuzumab (Campath)FDA Link
12/2021
1Neuroprotective AgentsIBA
12/2021
1HydrogelsIBA
10/2021
1CollagenIBA
10/2021
1polyrotaxaneIBA
10/2021
1AntigensIBA
08/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Cysteine (L-Cysteine)FDA Link
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1maleimideIBA
01/2020
1Natalizumab (Tysabri)FDA Link
05/2018
1Interferon-betaIBA
01/2018
1CytokinesIBA
07/2017
1Matrix Metalloproteinases (MMPs)IBA
07/2017
1InterleukinsIBA
06/2017
1Aquaporin 4IBA
01/2016
1Dihydrotachysterol (AT 10)IBA
08/2015
1AutoantibodiesIBA
07/2015
1SynucleinsIBA
12/2014
1erucylphosphocholineIBA
05/2014
1SteroidsIBA
05/2014
1Zanamivir (Relenza)FDA Link
09/2003
1Oseltamivir (Tamiflu)FDA Link
09/2003
1Antiviral Agents (Antivirals)IBA
09/2003

Therapy/Procedure

2Therapeutics
12/2021 - 09/2003
2Duration of Therapy
08/2019 - 05/2018
1Drug Therapy (Chemotherapy)
01/2020